Literature DB >> 15727293

Disposition kinetics, bioavailability and renal clearance of cefepime in calves.

M M Ismail1.   

Abstract

The pharmacokinetics of cefepime were studied following intravenous and intramuscular administration of 6.5 mg/kg in four female Friesian calves. Following single intravenous administration, the serum concentration-time curves of cefepime were best fitted using a two-compartment open model. The elimination half-life (t(1/2)beta) was 2.38+/-0.16 h, volume of distribution at steady state (Vdss) was 0.21 +/- 0.01 L/kg, and total body clearance (ClB) was 1.1 +/- 0.08 ml/min per kg. Following intramuscular administration, the drug was rapidly absorbed with an absorption half-life (t(1/2)ab) of 0.29+/-0.02 h; maximum serum concentration (Cmax) of 21.7 +/- 1.1 microg/ml was attained after (Tmax) 1.1 +/- 0.08 h; and the drug was eliminated with an elimination half-life (t(1/2)el) of 3.02 +/- 0.18 h. The systemic bioavailability (F) after intramuscular administration of cefepime in calves was 95.7% +/- 7.44%. The in vitro serum protein-binding tendency was 10.5-16.7%. Following administration by both routes, the drug was excreted in high concentrations in urine for 24 h post administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727293     DOI: 10.1023/b:verc.0000046738.52788.3c

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  32 in total

1.  [In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in the Netherlands].

Authors:  D J Mevius; E G Hartman
Journal:  Tijdschr Diergeneeskd       Date:  2000-03-01

2.  Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs.

Authors:  S Y Gardner; M G Papich
Journal:  J Vet Pharmacol Ther       Date:  2001-06       Impact factor: 1.786

3.  In vitro susceptibility of Escherichia coli strains isolated from diarrhoeic dairy calves to 15 antimicrobial agents.

Authors:  J A Orden; J A Ruiz-Santa-Quiteria; S García; D Cid; R De La Fuente
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2000-06

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Disposition of the cephalosporin cefepime in normal and renally impaired subjects.

Authors:  R H Barbhaiya; C A Knupp; S T Forgue; G R Matzke; C E Halstenson; J A Opsahl; K A Pittman
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

6.  Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

7.  In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.

Authors:  A Vuye; J Pijck
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 8.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

Review 9.  beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.

Authors:  C C Sanders; W E Sanders
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

10.  Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.

Authors:  R E Kessler; M Bies; R E Buck; D R Chisholm; T A Pursiano; Y H Tsai; M Misiek; K E Price; F Leitner
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more
  5 in total

1.  Influence of E. coli lipopolysaccharide induced fever on the plasma kinetics of cefepime in cross-bred calves.

Authors:  Y G Pawar; S K Sharma
Journal:  Vet Res Commun       Date:  2007-07-03       Impact factor: 2.459

2.  Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.

Authors:  A M Abd El-Aty; A Goudah; S M Mouneir; Y E Sunwoo; J H Jang; J G Shin; J H Shim; M Shimoda
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

3.  Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.

Authors:  Ayman Goudah; Samar M Mouneir; Jae-Han Shim; A M Abd El-Aty
Journal:  J Vet Sci       Date:  2006-06       Impact factor: 1.672

4.  Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.

Authors:  Femke J Taverne; Ingeborg M van Geijlswijk; Dick J J Heederik; Jaap A Wagenaar; Johan W Mouton
Journal:  BMC Vet Res       Date:  2016-09-06       Impact factor: 2.741

5.  Influence of flunixin on the disposition kinetic of cefepime in goats.

Authors:  Mohamed El-Hewaity
Journal:  Adv Pharmacol Sci       Date:  2014-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.